About the journal
Cancer Biotherapy and Radiopharmaceuticals is a journal published by Mary Ann Liebert, Inc. in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Mary Ann Liebert, Inc.
- ISSN
- 1084-9785 · 1557-8852
- Country
- United States
- Access
- Not open access / not declared
Index listings
- MEDLINE · 2000-01-01
- PUBMED · 2018-10-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2509
Last recorded publication year
2026
h-index
77
i10-index
1309
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 81%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Cancer biotherapy and radiopharmaceuticals
- Source type
- journal
- NLM unique ID (PubMed)
- 9605408
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
Show all subjects (50)
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Circular RNAs in diseases
- Circular RNAs in diseases
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Research and Treatments
- Cancer Research and Treatments
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- CAR-T cell therapy research
- CAR-T cell therapy research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Radiation Therapy and Dosimetry
- Radiation Therapy and Dosimetry
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Prostate Cancer Treatment and Research
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Prostate Cancer Treatment and Research
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
- Medical Imaging and Pathology Studies
- Medical Imaging and Pathology Studies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ